Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
ALK

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

ALK

Chemical Structure Cat. No. Product Name CAS No.
Neladalkib Chemical Structure
 BCP49757 Neladalkib 2739866-40-9
NVL-655 is an orally bioavailable, brain-penetrant anaplastic lymphoma kinase (ALK) inhibitor inhibitor being investigated for the treatment of non-small cell lung cancer.
BCX-9250 Chemical Structure
 BCP49293 BCX-9250 BCX-9250
BCX 9250, is an orally administered, small molecule, inhibitor of activin receptor-like kinase-2 (ALK2).
R-268712 Chemical Structure
 BCP25191 R-268712 879487-87-3
R-268712 is a specific inhibitor of activin receptor-like kinase 5 (ALK5). It is also an orally active transforming growth factor-β type I receptor inhibitor.
ZX-29 Chemical Structure
 BCP45485 ZX-29 2254805-62-2
ZX-29 is a potent and selective ALK inhibitor for ALK, ALK L1196M and ALK G1202R mutations, respectively.
TPX-0131 Chemical Structure
 BCP42131 TPX-0131 2648641-36-3
TPX-0131 is a CNS-penetrant, next-generation ALK inhibitor that has potency against wild-type ALK and a spectrum of acquired resistance mutations, especially the G1202R solvent front mutation and compound mutations, for which there are currently no effective therapies.
TL13-12 Chemical Structure
 BCP36914 TL13-12 2229037-04-9
TL13-12 is a novel selective anaplastic lymphoma kinase (ALK) degrader.
TL13-112 Chemical Structure
 BCP36884 TL13-112 2229037-19-6
TL13-112 shows chemically induced degradation of anaplastic lymphoma kinase (ALK).
MS4078 Chemical Structure
 BCP32539 MS4078 2229036-62-6
MS4078 is an anaplastic lymphoma kinase (ALK) PROTAC (degrader) with a Kd of 19 nM for binding affinity to ALK.
SAR348830 Chemical Structure
 BCP31069 SAR348830 1462949-64-9
SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
BIBF0775 Chemical Structure
 BCP30371 BIBF0775 334951-90-5
BIBF0775 is a potent and selective transforming growth factor β (TGFβ) type I receptor (Alk5) inhibitor with an IC50 of 34 nM.
123下一页末页共 39 条记录 1 / 4 页 
0086-13720134139